Persistent Hyperphosphataemia as a Surrogate Marker of Permanent Hypoparathyroidism After Total Thyroidectomy in a Resource‐Limited Setting

BACKGROUND: Permanent hypoparathyroidism remains a significant complication after total thyroidectomy (TT), particularly with rising thyroid cancer incidence and increasing surgical extent. Long-term consequences include hypocalcaemic symptoms, renal impairment, cardiovascular morbidity, neurocognitive dysfunction, reduced quality of life, and increased healthcare utilization. Although intact parathyroid hormone (iPTH) is the standard biomarker for diagnosis and surveillance, its availability and affordability remain limited in many low-resource settings. This prospective study evaluated the utility of serum phosphate as a surrogate marker for permanent hypoparathyroidism after TT. METHODS: This cohort study compared patients with and without permanent hypoparathyroidism, defined as iPTH < 10 pg/mL persisting beyond 6 months post-TT. Demographic, clinico-pathological, and biochemical variables, including serum calcium, phosphate, iPTH, and 25-hydroxyvitamin D (25OHD), were analyzed at baseline, postoperative day 2 (POD2), and 6 months. RESULTS: Among 328 patients (mean age 38.7 years; 77.1% women), transient postoperative hypoparathyroidism occurred in 195 (59.5%) and permanent hypoparathyroidism in 18 (5.5%). Multivariable analysis identified POD2 iPTH (odds ratio 10.7, 95% confidence intervals 1.3-88.1); parathyroid autotransplantation (OR 8.4[1.6-43.5]); six-month phosphate (OR 3.9[1.2-13.5]); six-month 25OHD level (OR 3.2[1.03-10.1]) and POD2 calcium (OR 1.7[1.0-3.0]) as independent predictors, each p < 0.05. In receiver operating characteristic analysis, both POD2 iPTH < 6 pg/mL (AUC = 0.781) and 6-month phosphate > 4.9 mg/dL (AUC = 0.743) demonstrated good discriminatory performance (p < 0.001) and were comparable by DeLong's test (p = 0.671). CONCLUSION: Postoperative iPTH below 6 pg/mL is the principal marker for early risk stratification of permanent hypoparathyroidism following TT, whereas persistent hyperphosphataemia may serve as a surrogate biochemical marker during long-term surveillance.

Authors

Institutions

Publication Details

Journal
World Journal of Surgery
Published
2026-11-13
DOI
https://doi.org/10.1002/wjs.70683
Primary Topic
Thyroid and Parathyroid Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Persistent Hyperphosphataemia as a Surrogate Marker of Permanent Hypoparathyroidism After Total Thyroidectomy in a Resource‐Limited Setting

Poongkodi Karunakaran, Rajeev Parameswaran, Rangarajan Rajamanickam
World Journal of Surgery
Thyroid and Parathyroid Surgery
article

Persistent Hyperphosphataemia as a Surrogate Marker of Permanent Hypoparathyroidism After Total Thyroidectomy in a Resource‐Limited Setting

Poongkodi Karunakaran, Rajeev Parameswaran, Rangarajan Rajamanickam
article en

Abstract

BACKGROUND: Permanent hypoparathyroidism remains a significant complication after total thyroidectomy (TT), particularly with rising thyroid cancer incidence and increasing surgical extent. Long-term consequences include hypocalcaemic symptoms, renal impairment, cardiovascular morbidity, neurocognitive dysfunction, reduced quality of life, and increased healthcare utilization. Although intact parathyroid hormone (iPTH) is the standard biomarker for diagnosis and surveillance, its availability and affordability remain limited in many low-resource settings. This prospective study evaluated the utility of serum phosphate as a surrogate marker for permanent hypoparathyroidism after TT. METHODS: This cohort study compared patients with and without permanent hypoparathyroidism, defined as iPTH < 10 pg/mL persisting beyond 6 months post-TT. Demographic, clinico-pathological, and biochemical variables, including serum calcium, phosphate, iPTH, and 25-hydroxyvitamin D (25OHD), were analyzed at baseline, postoperative day 2 (POD2), and 6 months. RESULTS: Among 328 patients (mean age 38.7 years; 77.1% women), transient postoperative hypoparathyroidism occurred in 195 (59.5%) and permanent hypoparathyroidism in 18 (5.5%). Multivariable analysis identified POD2 iPTH (odds ratio 10.7, 95% confidence intervals 1.3-88.1); parathyroid autotransplantation (OR 8.4[1.6-43.5]); six-month phosphate (OR 3.9[1.2-13.5]); six-month 25OHD level (OR 3.2[1.03-10.1]) and POD2 calcium (OR 1.7[1.0-3.0]) as independent predictors, each p < 0.05. In receiver operating characteristic analysis, both POD2 iPTH < 6 pg/mL (AUC = 0.781) and 6-month phosphate > 4.9 mg/dL (AUC = 0.743) demonstrated good discriminatory performance (p < 0.001) and were comparable by DeLong's test (p = 0.671). CONCLUSION: Postoperative iPTH below 6 pg/mL is the principal marker for early risk stratification of permanent hypoparathyroidism following TT, whereas persistent hyperphosphataemia may serve as a surrogate biochemical marker during long-term surveillance.

World Journal of Surgery
Tamil Nadu Dr. M.G.R. Medical University (IN), National University Hospital (SG), Government Mohan Kumaramangalam Medical College (IN)
Thyroid and Parathyroid Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon